Vimta Labs Share Price

NSE
VIMTALABS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Vimta Labs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
108.54% Gain from 52W Low
52.9
TTM PE Ratio
Above industry Median
31.7
Price to Book Ratio
Above industry Median
5.7
Dividend yield 1yr %
Below industry Median
0.2
TTM PEG Ratio
PEG TTM is less than 1
0.7

Vimta Labs Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Vimta Labs Ltd Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
89.92 Cr
84.74 Cr
81.76 Cr
79.69 Cr
81.68 Cr

Vimta Labs Ltd Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
322.27 Cr
321.63 Cr
279.73 Cr
211.51 Cr
183.73 Cr

Vimta Labs Ltd Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
17.52 Cr
17.02 Cr
12.28 Cr
12.35 Cr
10.13 Cr

Vimta Labs Ltd Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
41.01 Cr
48.17 Cr
41.33 Cr
21.4 Cr
6.84 Cr
Vimta Labs Ltd Result Highlights
  • Vimta Labs Ltd reported a 6.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 10.4%.

  • Its expenses for the quarter were up by 5.8% QoQ and down 2.7% YoY.

  • The net profit increased 41.0% QoQ and increased 112.2% YoY.

  • The earnings per share (EPS) of Vimta Labs Ltd stood at 9.6 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Vimta Labs Ltd shareholding Pattern

Promoter
36.8%
Foreign Institutions
3.8%
Mutual Funds
0.1%
Domestic Institutions
1.2%
Public
58.3%
Promoter
36.9%
Foreign Institutions
3.3%
Public
59.8%
Promoter
36.9%
Foreign Institutions
5.2%
Mutual Funds
1.5%
Domestic Institutions
1.4%
Public
56.4%
Promoter
36.9%
Foreign Institutions
5.1%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
56.4%
Promoter
37%
Foreign Institutions
2.9%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
58.6%
Promoter
37%
Foreign Institutions
2.7%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
58.8%

Vimta Labs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
11
Bearish Moving Averages
5
5Day EMA
855.10
10Day EMA
858.30
12Day EMA
862.20
20Day EMA
877.20
26Day EMA
882.90
50Day EMA
866.50
100Day EMA
791.60
200Day EMA
690.00
5Day SMA
843.00
10Day SMA
853.60
20Day SMA
886.30
30Day SMA
918.00
50Day SMA
922.40
100Day SMA
759.60
150Day SMA
687.20
200Day SMA
638.60
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
24971 Rs
55233 Rs
Week Rs
61667 Rs
145670 Rs
Month Rs
56718 Rs
146069 Rs
Resistance & Support
873.65
Pivot
Resistance
First Resistance
896.10
Second Resistance
916.35
Third Resistance
938.80
Support
First Support
853.40
Second support
830.95
Third Support
810.70
Relative Strength Index
48.86
Money Flow Index
58.50
MACD
-20.72
MACD Signal
-18.37
Average True Range
56.21
Average Directional Index
19.57
Rate of Change (21)
-7.43
Rate of Change (125)
72.34

Vimta Labs Ltd Company background

Founded in: 1990
Managing director: Harita Vasireddi
Vimta Labs Ltd., established in 1984, is Indias most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and nonGLP), clinical research, central lab, and cGMP as well as nonGMP analytical services for pharmaceutical and biopharmaceutical companies Preclinical research and testing services for medical device companies Contract research and testing for Agroscience companies Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil gas, mining etc EMI/EMC testing for electronic and electrical products.In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.During the year 200607, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006.During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company.In 202324, Emtac Laboratories Private Limited got amalgamated with the Company effective 01.04.2024.
Read More

Vimta Labs Ltd FAQs

Vimta Labs Ltd shares are currently priced at 875.85 on NSE and 876.55 on BSE as of 1/31/2025 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Vimta Labs Ltd [VIMTALABS] share was 92.89. The Vimta Labs Ltd [VIMTALABS] share hit a 1-year low of Rs. 420 and a 1-year high of Rs. 1069.95.

The market cap of Vimta Labs Ltd is Rs. 1945.55 Cr. as of 1/31/2025 12:00:00 AM.

The PE ratios of Vimta Labs Ltd is 33.29 as of 1/31/2025 12:00:00 AM.

The PB ratios of Vimta Labs Ltd is 5.75 as of 1/31/2025 12:00:00 AM

The Mutual Fund Shareholding was 0.13% at the end of 1/31/2025 12:00:00 AM.

You can easily buy Vimta Labs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -